Amgen cancer drug OKd by EU
- Share via
From Times Wire Services
Amgen Inc. received European Commission approval to market its drug Vectibix for use by colon cancer patients after standard chemotherapy procedures fail.
The clearance was based on a positive risk/benefit ratio for seriously ill patients who have few treatment options, the Thousand Oaks-based company said.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
